NCT01197781View on ClinicalTrials.gov

Evaluation of the Drug-drug Interaction Between FosD and Verapamil When Taken Together in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Drug Drug InteractionsHealthy Volunteers
Interventions
DRUG

FOSTAMATIN

Oral tablets - single dose

DRUG

Verapamil

Oral tablets - administered 3 times daily over 4 days

Trial Locations (1)

Unknown

Recruiting Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT01197781 - Evaluation of the Drug-drug Interaction Between FosD and Verapamil When Taken Together in Healthy Volunteers | Biotech Hunter | Biotech Hunter